Ropes and Gray: Novo Enters Global Licensing Deal Up to $1.3 Billion for Nanexa Drug Delivery Injection Technology
September 26, 2026
September 26, 2026
BOSTON, Massachusetts, Sept. 26 -- Ropes and Gray, a law firm, issued the following news:
* * *
Novo Enters Global Licensing Deal up to $1.3 Billion for Nanexa Drug Delivery Injection Technology
September 25, 2026
Ropes & Gray advised Novo in a global licensing agreement with Swedish drug delivery company Nanexa AB worth up to $1.3 billion to develop longer-lasting injectable treatments for obesity, type 2 diabetes, and other cardiometaboli . . .
* * *
Novo Enters Global Licensing Deal up to $1.3 Billion for Nanexa Drug Delivery Injection Technology
September 25, 2026
Ropes & Gray advised Novo in a global licensing agreement with Swedish drug delivery company Nanexa AB worth up to $1.3 billion to develop longer-lasting injectable treatments for obesity, type 2 diabetes, and other cardiometaboli . . .